INTERNATIONAL PATENT: OLIX PHARMACEUTICALS, INC. FILES APPLICATION FOR "RNAI AGENT TARGETING APOC3 GENE AND USE THEREOF"

GENEVA, March 10 -- OLIX PHARMACEUTICALS, INC. (Rm.1014, 17, Daehak 4-ro, Yeongtong-gu,Suwon-si,Gyeonggi-do 16226) filed a patent application (PCT/KR2025/013220) for "RNAi AGENT TARGETING APOC3 GENE AND USE THEREOF" on Aug 28, 2025. With publication no. WO/2026/049536, the details related to the patent application was published on Mar 05, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): PARK, June Hyun (208-503, 34 Geumdang-ro 39beon-gil, Jangan-gu,Suwon-si,Gyeonggi-do 16281), CHOE, Jeong Yong (111-2102, 22 Gyeongsu-daero 976beon-gil, Jangan-gu,Suwon-si,Gyeonggi-do 16295)

Abstract: The discl...